+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in the development of cinnamic-like derivatives as antituberculosis agents



Recent advances in the development of cinnamic-like derivatives as antituberculosis agents



Expert Opinion on Therapeutic Patents 22(2): 155-168



The high susceptibility of human immunodeficiency virus-infected people to tuberculosis (TB), the emergence of multi-drug-resistant (MDR-TB) strains and extensively drug-resistant (XDR-TB) ones, has brought TB into the focus of urgent scientific interest. As a result, there has been an upsurge in recent years to find new anti-TB agents, with the cinnamoyl moiety having been identified as a particularly simple and effective pharmacophore for this purpose. This review aims at highlighting the potential of (non)natural cinnamic derivatives to treat TB. It provides an overview of the worldwide recent patent and literature surrounding this type of easy-to-prepare small molecules. There is a special focus on their salient structural and chemical features involved in the reported anti-TB activities. Cinnamic derivatives clearly appear as attractive drug candidates to combat TB. So far, literature has reported that they are easy to synthesize and have promising anti-TB activities. Nevertheless, the mode(s) of action of these small molecules remain(s) to date obscure, which is why the implicated molecular mechanisms deserve to be investigated in further detail in the near future.

(PDF emailed within 0-6 h: $19.90)

Accession: 055398862

Download citation: RISBibTeXText

PMID: 22329571

DOI: 10.1517/13543776.2012.661717


Related references

Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents. Bioorganic & Medicinal Chemistry Letters 19(2): 341-343, 2009

Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents. Journal of Medicinal Chemistry 54(5): 1449-1461, 2011

Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. European Journal of Medicinal Chemistry 100: 257-269, 2016

Studies On The Antituberculosis Activity Of Derivatives Of Cinnamic Acid Hydrazide. Kekkaku 39: 74-78, 1964

Antituberculosis agents X Synthesis and evaluation of in vitro antituberculosis activity of 2- - and 2- -1,3,4-thiadiazole derivatives. Archives of Pharmacal Research (Seoul) 27(5): 502-506, 2004

Antituberculosis agents, I: Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives. Die Pharmazie 56(8): 610-612, 2001

Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Farmaco (Lausanne) 56(8): 621-623, 2001

Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives. Farmaco 57(9): 765-769, 2002

Antituberculosis agents X. Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives. Archives of Pharmacal Research 27(5): 502-506, 2004

Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents. Current Medicinal Chemistry 11(10): 1265-1284, 2004

Sulphur-Containing Heterocycles as Antimycobacterial Agents: Recent Advances in Thiophene and Thiadiazole Derivatives. Current Topics in Medicinal Chemistry 16(26): 2921-2952, 2016

Recent advances in antituberculosis chemotherapy. Xianggang Hu Li Za Zhi. Hong Kong Nursing Journal: 19-27, 1979

Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents. European Journal of Medicinal Chemistry 46(11): 5609-5615, 2012